Fiche société
The Centre for Advanced Research & Development, India
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications1liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| CytotronThe purpose of the study is to evaluate the efficacy of RFQMR therapy in remyelination in cases of Multiple sclerosis. The evaluation will be done based on MRI findings, by clinical/ neurological examination and by assessment of quality of life before and after completion of therapy. | SEP | Phase 2 | Remyélinisation | India | À vérifier |
| CytotronThe purpose of the study is to evaluate the efficacy of RFQMR therapy in remyelination in cases of Multiple sclerosis. The evaluation will be done based on MRI findings, by clinical/ neurological examination and by assessment of quality of life before and after completion of therapy. | SEP | Phase 2 | Remyélinisation | India | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Cytotron | SEP | Phase 2 | NCT01220830 | RFQMR — Cytotron® Delivered Rotational Field Quantum Nuclear Magnetic Resonance Therapy for Multiple Sclerosis | UNKNOWN |
Publications
1| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Cytotron | The lymphocyte phenotype in patients with primary fibromyalgia. | Upsala journal of medical sciences |